Quarterly report pursuant to Section 13 or 15(d)

Commitments and Contingencies (Details)

v2.4.0.8
Commitments and Contingencies (Details) (USD $)
Jun. 30, 2013
Dec. 31, 2012
Dec. 31, 2011
Dec. 31, 2006
Research and development contracts $ 70,851      
Theradex work order agreement 1,880,940      
Patent license agreement 120,000      
Liquidated damages payable under registration rights agreement 74,000 74,000 74,000 74,000
Due to stockholder 92,717      
Total 2,238,508      
Payments Due By 2013 [Member]
       
Research and development contracts 70,851      
Theradex work order agreement 480,940      
Patent license agreement 0      
Liquidated damages payable under registration rights agreement 74,000      
Due to stockholder 92,717      
Total 718,508      
Payments Due By 2014 [Member]
       
Research and development contracts 0      
Theradex work order agreement 1,000,000      
Patent license agreement 30,000      
Due to stockholder 0      
Total 1,030,000      
Payments Due By 2015 [Member]
       
Research and development contracts 0      
Theradex work order agreement 400,000      
Patent license agreement 30,000      
Liquidated damages payable under registration rights agreement 0      
Due to stockholder 0      
Total 430,000      
Payments Due By 2016 [Member]
       
Research and development contracts 0      
Theradex work order agreement 0      
Patent license agreement 30,000      
Liquidated damages payable under registration rights agreement 0      
Due to stockholder 0      
Total 30,000      
Payments Due By 2017 [Member]
       
Research and development contracts 0      
Theradex work order agreement 0      
Patent license agreement 30,000      
Liquidated damages payable under registration rights agreement 0      
Due to stockholder 0      
Total $ 30,000